Expert Insights
Pharmaceutical Industry News Roundup: April 2020
By Staff Writer, April 30, 2020
Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection from April 2020.
With Safety, Urgency, and Innovation: How an Award-Winning CRO Operates During COVID-19
By Staff Writer, April 28, 2020
The COVID-19 pandemic has impacted the way many pharmaceutical, biotech, and CRO companies are working, rewarding flexibility and agile resourcing and operating models. In this expert insights blog, we sit down (virtually) with Kelly J. Hill, Executive Director, Global Business Operations and Strategy and Michelle Gayari, Executive Director, Global Operations to learn how MMS operates with safety, urgency, and innovation during this pandemic.
Whitepaper: Six Changes that Pharmaceutical Companies Should Consider in Response to COVID-19
Experts at MMS have reviewed COVID-19 guidance documents and taken into account the current state of clinical research globally to ensure our services align with these new challenges, whether those sponsors be virtual or large firms with treatments for common illnesses or rare conditions. What has been identified in this whitepaper are key areas of change faced by the industry.
Unprecedented does not have to mean unprepared: Business Continuity Planning
by Jessica Alamdari, April 3, 2020
During these unprecedented times, many businesses are struggling to continue business as usual while the world is rapidly changing around them; however, certain businesses continue to thrive. Throughout this COVID-19 pandemic, companies like MMS, among other leaders in the pharmaceutical industry, are not only carrying out typical day-to-day business operations, but they are well-positioned to offer additional support to companies unable to adapt.
Pharmaceutical Industry News Roundup: March 2020
by Staff Writer, March 25, 2020
Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection from March 2020.
The Circle of Concern vs the Circle of Influence: A Conversation with Dr. Uma Sharma
by Staff Writer, March 17, 2020
In this Expert Insights interview, we sit down with Dr. Uma Sharma, Chief Scientific Officer at MMS Holdings. Dr. Sharma discusses her thoughts surrounding the Circle of Concern and the Circle of Influence, including how it influences the culture at MMS.
Pharmaceutical Industry News Roundup: February 2020
by Staff writer
Each month, MMS shares key stories on the evolution of the pharmaceutical industry. February’s news includes coronavirus vaccine development, saving 7 million lives from cancer, and more.
The New Roaring 20s: 12 Experts Provide Pharmaceutical Insights for the Decade Ahead
by Aaron Robert, February 7, 2020
The pharmaceutical industry—and healthcare in general—are in constant stages of innovation. According to the International Federation of Pharmaceutical Manufacturers & Associations, the number of new chemical or biological entities launched on the world market stood at 226 from the years 2011 to 2015, a 35 percent increase from the decade prior.
Pharmaceutical Industry News Roundup: November 2019
by Staff Writer
Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection from November 2019.
Pharmaceutical Industry News Roundup: October 2019
by Staff Writer
Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection from October 2019…
6880 Commerce Blvd.
Canton, MI 48187 USA
734.245.0310 T
734.245.0320 F
